Management of intracranial fungal infections in patients with haematological malignanciesMATTIUZZI, Gloria; GILES, Francis J.British journal of haematology. 2005, Vol 131, Num 3, pp 287-300, issn 0007-1048, 14 p.Article

New Directions in the Treatment of Imatinib Failure and/or ResistanceGILES, Francis J.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S27-S33, SUP3Article

Mammalian target of rapamycin inhibition as therapy for hematologic malignanciesPANWALKAR, Amit; VERSTOVSEK, Srdan; GILES, Francis J et al.Cancer. 2004, Vol 100, Num 4, pp 657-666, issn 0008-543X, 10 p.Article

Amifostine and hematologic effectsSRISWASDI, Chantrapa; JOOTAR, Saengsuree; GILES, Francis J et al.Chot Mai Het Thang Phaet. 2000, Vol 83, Num 4, pp 374-382, issn 0125-2208, 9 p.Article

Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomasTSIMBERIDOU, Apostolia-Maria; GILES, Francis J; DUVIC, Madeleine et al.Journal of the American Academy of Dermatology. 2004, Vol 51, Num 2, pp 200-204, issn 0190-9622, 5 p.Article

Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemiaCOLBURN, Dawn E; THOMAS, Deborah A; GILES, Francis J et al.Investigational new drugs. 2003, Vol 21, Num 1, pp 109-111, issn 0167-6997, 3 p.Article

Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: Recall following different chemotherapy agentsYUK FUNG HUI; GILES, Francis J; CORTES, Jorge E et al.Investigational new drugs. 2002, Vol 20, Num 1, pp 49-53, issn 0167-6997, 5 p.Article

Use of mTOR inhibitors in the treatment of malignanciesMOHINDRA, Nisha A; GILES, Francis J; PLATANIAS, Leonidas C et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 7, pp 979-990, issn 1465-6566, 12 p.Article

New approaches in the treatment of myelofibrosisHENNESSY, Bryan T; THOMAS, Deborah A; GILES, Francis J et al.Cancer. 2005, Vol 103, Num 1, pp 32-43, issn 0008-543X, 12 p.Article

Therapeutic choices in younger patients with chronic myelogenous leukemiaKANTARJIAN, Hagop M; GILES, Francis J; O'BRIEN, Susan et al.Cancer. 2000, Vol 89, Num 8, pp 1647-1658, issn 0008-543XArticle

5-Azacytidine for the treatment of myelodysplastic syndromesKRAWCZYK, Janusz; KEANE, Niamh; FREEMAN, Ciara Louise et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 9, pp 1255-1268, issn 1465-6566, 14 p.Article

Current and emerging treatment options in chronic myeloid leukemiaJABBOUR, Elias; CORTES, Jorge E; GILES, Francis J et al.Cancer. 2007, Vol 109, Num 11, pp 2171-2181, issn 0008-543X, 11 p.Article

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatmentTSIMBERIDOU, Apostolia-Maria; WADDELOW, Tracey; KANTARJIAN, Hagop M et al.Leukemia research. 2003, Vol 27, Num 5, pp 375-380, issn 0145-2126, 6 p.Article

Antiangiogenic therapy in leukemiaTHOMAS, Deborah A; GILES, Francis J; CORTES, Jorge et al.Acta haematologica. 2001, Vol 106, Num 4, pp 190-207, issn 0001-5792Article

Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasmsPAZDUR, R.British journal of haematology. 1991, Vol 79, pp 56-59, issn 0007-1048, SUP1Conference Paper

Retinoids and interferon : a new promising combination ?BOLLAG, W.British journal of haematology. 1991, Vol 79, pp 87-91, issn 0007-1048, SUP1Conference Paper

Molecular cloning of interferon receptors : a short reviewAGUET, M.British journal of haematology. 1991, Vol 79, pp 6-8, issn 0007-1048, SUP1Conference Paper

Clinical cardiac safety profile of nilotinibKIM, Theo D; LE COUTRE, Philipp; SCHWARZ, Michaela et al.Haematologica (Roma). 2012, Vol 97, Num 6, pp 883-889, issn 0390-6078, 7 p.Article

Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanismKELLY, Kevin R; NAWROCKI, Steffan T; ESPITIA, Claudia M et al.International journal of cancer (Print). 2012, Vol 131, Num 11, pp 2693-2703, issn 0020-7136, 11 p.Article

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKANTARJIAN, Hagop M; GILES, Francis J; HUGHES, Timothy P et al.Blood. 2011, Vol 117, Num 4, pp 1141-1145, issn 0006-4971, 5 p.Article

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapyKANTARJIAN, Hagop M; GILES, Francis J; GREENBERG, Peter L et al.Blood. 2010, Vol 116, Num 17, pp 3163-3170, issn 0006-4971, 8 p.Article

Rotary powered device for bone marrow aspiration and biopsy yields excellent specimens quickly and efficientlySWORDS, Ronan T; KELLY, Kevin R; COHEN, Stephen C et al.Journal of clinical pathology. 2010, Vol 63, Num 6, pp 562-565, issn 0021-9746, 4 p.Article

WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F MutationVERSTOVSEK, Srdan; MANSHOURI, Taghi; QUINTAS-CARDAMA, Alfonso et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 788-796, issn 1078-0432, 9 p.Article

Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemiaALBITAR, Maher; POTTS, Steven J; KANTARJIAN, Hagop et al.Cancer. 2006, Vol 106, Num 7, pp 1587-1594, issn 0008-543X, 8 p.Article

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylateTHOMAS, Deborah A; FADERL, Stefan; BERAN, Miloslav et al.Blood. 2004, Vol 103, Num 12, pp 4396-4407, issn 0006-4971, 12 p.Article